References
- Wong WB , AninaD , LinC-W , AdamsDV. Alignment of health plan coverage policies for somatic multigene panel testing with clinical guidelines in select solid tumors. Per. Med.19(3), 171–180 (2022).
- Roman YM . The United States 2020 census data: implications for precision medicine and the research landscape. Per. Med.19(1), 5–8 (2022)
- Ahmed Z , RenartEG , ZeeshanS. Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-19. Per. Med.19(3), 229–250 (2022).
- Moorthie S , AlisonHall , de VilliersCBet al. How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests? Per. Med. 19(3), 63–270 (2022).
- Alrajeh KY , RomanYM. The frequency of major CYP2C19 genetic polymorphisms in women of Asian, Native Hawaiian and Pacific Islander subgroups. Per. Med.19(4), 327–339 (2022).
- Adeleke S , HaslamA , ChoyAet al. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls. Per. Med.19(4), 277–286 (2022).
- Rahman B , McEwenA , PhillipsJL , TuckerK , GoldsteinD , JacobsC. Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review. Per. Med.19(2), 139–153 (2022).
- Limkakeng AT , RowletteL-L , HatchAet al. A precision medicine approach to stress testing using metabolomics and microribonucleic acids. Per. Med.19(4), 287–297 (2022).
- Waldman CE , MinJH , WassifHet al. COVID-19 telehealth preparedness: a cross-sectional assessment of cardiology practices in the USA. Per. Med.19(5), 411–422 (2022).